Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	VX-371 + Hypertonic Saline	0	89
Total, all-cause mortality	Hypertonic Saline	0	90
Total, all-cause mortality	VX-371 + Placebo	0	46
Total, all-cause mortality	Placebo	0	42
Total, other adverse events	VX-371 + Hypertonic Saline	49	89
Total, other adverse events	Hypertonic Saline	55	90
Total, other adverse events	VX-371 + Placebo	26	46
Total, other adverse events	Placebo	20	42
Total, serious adverse events	VX-371 + Hypertonic Saline	8	89
Total, serious adverse events	Hypertonic Saline	4	90
Total, serious adverse events	VX-371 + Placebo	6	46
Total, serious adverse events	Placebo	3	42

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02709109/event-totals